Jatenzo Approval Status
- FDA approved: No
- Brand name: Jatenzo
- Generic name: testosterone undecanoate
- Previous name: Rextoro
- Company: Clarus Therapeutics, Inc.
- Treatment for: Hypogonadism, Male
Jatenzo (testosterone undecanoate) is an oral testosterone replacement therapy in development for the treatment of low testosterone in hypogonadal men.
Development Status and FDA Approval Process for Jatenzo
|Jun 26, 2017||Clarus Re-submits Jatenzo NDA Following Positive Results of inTUne Trial|
|Jan 13, 2014||Clarus Therapeutics Submits New Drug Application for Rextoro (formerly CLR-610) for the treatment of Low Testosterone|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.